Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus – A Nationwide Registry Study

Emil Karonen,1,2 Frida Eek,3 Isabel Drake,4 Talha Butt,1,2 Hanne Krage Carlsen,5 Björn Eliasson,6 Anders Gottsäter,1,7 Stefan Acosta1,2 1Department of Clinical Sciences, Lund University, Malmö, Sweden; 2Vascular Centre, Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Karonen E, Eek F, Drake I, Butt T, Carlsen HK, Eliasson B, Gottsäter A, Acosta S
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Vascular Health and Risk Management
Subjects:
Online Access:https://www.dovepress.com/comparison-of-outcomes-after-revascularization-for-acute-lower-limb-is-peer-reviewed-fulltext-article-VHRM
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850185160738209792
author Karonen E
Eek F
Drake I
Butt T
Carlsen HK
Eliasson B
Gottsäter A
Acosta S
author_facet Karonen E
Eek F
Drake I
Butt T
Carlsen HK
Eliasson B
Gottsäter A
Acosta S
author_sort Karonen E
collection DOAJ
description Emil Karonen,1,2 Frida Eek,3 Isabel Drake,4 Talha Butt,1,2 Hanne Krage Carlsen,5 Björn Eliasson,6 Anders Gottsäter,1,7 Stefan Acosta1,2 1Department of Clinical Sciences, Lund University, Malmö, Sweden; 2Vascular Centre, Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Malmö, Sweden; 3Department of Health Sciences, Lund University, Lund, Sweden; 4Diabetes and Cardiovascular Disease-Genetic Epidemiology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden; 5Centre of Registers, National Diabetes Register, Göteborg, Sweden; 6Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Göteborg, Sweden; 7Department of Medicine, Skåne University Hospital, Malmö, SwedenCorrespondence: Emil Karonen, Department of Clinical Sciences, Lund University Ruth Lundskogs Gata 10, Malmö, 205 02, Sweden, Email emil.karonen@med.lu.seIntroduction: Acute lower limb ischemia (ALI) is a life and limb threatening event often affecting patients with type 2 diabetes mellitus (T2DM). Little is known about how T2DM affects the risk of adverse events in patients revascularized for ALI. This study aimed to investigate if there were differences in major outcomes between ALI patients with and without T2DM.Methods: Between 2010 and 2014, 615 patients underwent revascularization for ALI, according to the Swedish Vascular Registry (SWEDVASC). Using the National Diabetes Registry (NDR), 245 (39.8%) of the patients were identified as having T2DM. Uni- and multivariable Cox or logistic regression analyses were performed to evaluate risk differences for major amputation, mortality, major adverse cardiovascular events (MACE), and fasciotomy between patients with and without T2DM.Results: The rates of major amputation and mortality at one year were 32.7% and 21.6% in the T2DM group, compared to 21.9% and 31.9% in the non-DM group, respectively, resulting in a hazard ratio (HR) of 1.52 (95% confidence interval [CI] 1.12– 2.07) for major amputation and HR of 0.64 (95% CI 0.46– 0.88) for mortality. At one year, the HR for major amputation was 1.45 (95% CI 0.99– 2.11), HR for mortality 0.92 (95% CI 0.61– 1.39), HR for combined major amputation/mortality 1.27 (95% CI 0.94– 1.72), and HR for MACE 1.24 (95% CI 0.92– 1.67) for those with T2DM compared to those without in the multivariable Cox-regression analyses. The multivariable logistic regression analysis showed significantly lower odds of fasciotomy, OR 0.1 (95% CI 0.01– 0.51) in the T2DM-group.Conclusion: T2DM was not significantly associated with higher hazard of major amputation, mortality, combined major amputation/mortality, or MACE after revascularization for ALI, compared to patients without T2DM. Patients with T2DM had significantly lower odds of fasciotomy.Keywords: acute lower limb ischemia, type 2 diabetes mellitus, major amputation
format Article
id doaj-art-3495c2fbcf1e4030bd51fa0e8c675de5
institution OA Journals
issn 1178-2048
language English
publishDate 2025-04-01
publisher Dove Medical Press
record_format Article
series Vascular Health and Risk Management
spelling doaj-art-3495c2fbcf1e4030bd51fa0e8c675de52025-08-20T02:16:49ZengDove Medical PressVascular Health and Risk Management1178-20482025-04-01Volume 21229238101979Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus – A Nationwide Registry StudyKaronen EEek FDrake IButt TCarlsen HKEliasson BGottsäter AAcosta SEmil Karonen,1,2 Frida Eek,3 Isabel Drake,4 Talha Butt,1,2 Hanne Krage Carlsen,5 Björn Eliasson,6 Anders Gottsäter,1,7 Stefan Acosta1,2 1Department of Clinical Sciences, Lund University, Malmö, Sweden; 2Vascular Centre, Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Malmö, Sweden; 3Department of Health Sciences, Lund University, Lund, Sweden; 4Diabetes and Cardiovascular Disease-Genetic Epidemiology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden; 5Centre of Registers, National Diabetes Register, Göteborg, Sweden; 6Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Göteborg, Sweden; 7Department of Medicine, Skåne University Hospital, Malmö, SwedenCorrespondence: Emil Karonen, Department of Clinical Sciences, Lund University Ruth Lundskogs Gata 10, Malmö, 205 02, Sweden, Email emil.karonen@med.lu.seIntroduction: Acute lower limb ischemia (ALI) is a life and limb threatening event often affecting patients with type 2 diabetes mellitus (T2DM). Little is known about how T2DM affects the risk of adverse events in patients revascularized for ALI. This study aimed to investigate if there were differences in major outcomes between ALI patients with and without T2DM.Methods: Between 2010 and 2014, 615 patients underwent revascularization for ALI, according to the Swedish Vascular Registry (SWEDVASC). Using the National Diabetes Registry (NDR), 245 (39.8%) of the patients were identified as having T2DM. Uni- and multivariable Cox or logistic regression analyses were performed to evaluate risk differences for major amputation, mortality, major adverse cardiovascular events (MACE), and fasciotomy between patients with and without T2DM.Results: The rates of major amputation and mortality at one year were 32.7% and 21.6% in the T2DM group, compared to 21.9% and 31.9% in the non-DM group, respectively, resulting in a hazard ratio (HR) of 1.52 (95% confidence interval [CI] 1.12– 2.07) for major amputation and HR of 0.64 (95% CI 0.46– 0.88) for mortality. At one year, the HR for major amputation was 1.45 (95% CI 0.99– 2.11), HR for mortality 0.92 (95% CI 0.61– 1.39), HR for combined major amputation/mortality 1.27 (95% CI 0.94– 1.72), and HR for MACE 1.24 (95% CI 0.92– 1.67) for those with T2DM compared to those without in the multivariable Cox-regression analyses. The multivariable logistic regression analysis showed significantly lower odds of fasciotomy, OR 0.1 (95% CI 0.01– 0.51) in the T2DM-group.Conclusion: T2DM was not significantly associated with higher hazard of major amputation, mortality, combined major amputation/mortality, or MACE after revascularization for ALI, compared to patients without T2DM. Patients with T2DM had significantly lower odds of fasciotomy.Keywords: acute lower limb ischemia, type 2 diabetes mellitus, major amputationhttps://www.dovepress.com/comparison-of-outcomes-after-revascularization-for-acute-lower-limb-is-peer-reviewed-fulltext-article-VHRMacute lower limb ischemiatype 2 diabetes mellitusmajor amputation
spellingShingle Karonen E
Eek F
Drake I
Butt T
Carlsen HK
Eliasson B
Gottsäter A
Acosta S
Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus – A Nationwide Registry Study
Vascular Health and Risk Management
acute lower limb ischemia
type 2 diabetes mellitus
major amputation
title Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus – A Nationwide Registry Study
title_full Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus – A Nationwide Registry Study
title_fullStr Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus – A Nationwide Registry Study
title_full_unstemmed Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus – A Nationwide Registry Study
title_short Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus – A Nationwide Registry Study
title_sort comparison of outcomes after revascularization for acute lower limb ischemia in patients with and without type 2 diabetes mellitus ndash a nationwide registry study
topic acute lower limb ischemia
type 2 diabetes mellitus
major amputation
url https://www.dovepress.com/comparison-of-outcomes-after-revascularization-for-acute-lower-limb-is-peer-reviewed-fulltext-article-VHRM
work_keys_str_mv AT karonene comparisonofoutcomesafterrevascularizationforacutelowerlimbischemiainpatientswithandwithouttype2diabetesmellitusndashanationwideregistrystudy
AT eekf comparisonofoutcomesafterrevascularizationforacutelowerlimbischemiainpatientswithandwithouttype2diabetesmellitusndashanationwideregistrystudy
AT drakei comparisonofoutcomesafterrevascularizationforacutelowerlimbischemiainpatientswithandwithouttype2diabetesmellitusndashanationwideregistrystudy
AT buttt comparisonofoutcomesafterrevascularizationforacutelowerlimbischemiainpatientswithandwithouttype2diabetesmellitusndashanationwideregistrystudy
AT carlsenhk comparisonofoutcomesafterrevascularizationforacutelowerlimbischemiainpatientswithandwithouttype2diabetesmellitusndashanationwideregistrystudy
AT eliassonb comparisonofoutcomesafterrevascularizationforacutelowerlimbischemiainpatientswithandwithouttype2diabetesmellitusndashanationwideregistrystudy
AT gottsatera comparisonofoutcomesafterrevascularizationforacutelowerlimbischemiainpatientswithandwithouttype2diabetesmellitusndashanationwideregistrystudy
AT acostas comparisonofoutcomesafterrevascularizationforacutelowerlimbischemiainpatientswithandwithouttype2diabetesmellitusndashanationwideregistrystudy